SLC6A3 and Alzheimer disease: Although in vivo amyloid positron emission tomography (PET) and dopamine transporter (DAT) imaging have enabled the antemortem diagnosis of AD and LBD4,5, performing DAT imaging as a routine evaluation in the memory clinic could be difficult due to cost-related issues.